This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Jared Haft Goldstein, MD

JAMA. 1991;265(18):2391-2392.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

THERE was once a time when I prided myself on my control of my relationship with drug companies. They talked, they cajoled, they bribed, they hinted; I remained pure. No claim went unchallenged; no treatment choices were made at their behest. Journal advertisements, detail visits, logo-covered trinkets: I was immune to their blandishments. My critical faculties were placed on instant alert at the hint of a marketing maneuver. My patients were secure, my professional ethics always intact. I knew that a good doctor was a good skeptic, and I kept my skills sharpened on the primitive efforts the admen made to mislead me.

Times, and I, have changed. I have come to believe that skepticism is an inadequate defense against undesired influence. I can no longer claim that I have remained unaffected by two decades of continual contact with a barrage of marketing. Indeed, I am no longer even sure . . . [Full Text PDF of this Article]

Author Affiliations
From the Randleman (NC) Family Health Center.

Footnotes
Reprint requests to Randleman Family Health Center, 702 S Main St, Randleman, NC 27317 (Dr Goldstein).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?